NCT00018278

Data

{
  "briefSummary": "The main purpose of this study is to determine the electrophysiological effects of cholinergic therapy (cholinesterase inhibitors and transdermal nicotine) in Alzheimer disease. The attempt will be to locate electrophysiological markers and predictors of cognitive and clinical treatment response.",
  "completionDate": "2001-09",
  "conditions": [
    "Alzheimer Disease"
  ],
  "enrollmentCount": null,
  "enrollmentType": null,
  "nctId": "NCT00018278",
  "phase": "PHASE4",
  "sponsorId": "us-department-of-veterans-affairs",
  "startDate": "1998-10",
  "status": "COMPLETED",
  "studyType": "INTERVENTIONAL",
  "title": "Verbal Memory ERPs as Indices of Treatment Response in Alzheimer Disease",
  "url": "https://clinicaltrials.gov/study/NCT00018278"
}

History in this collection

1. addedv1.0.0Jun 12, 2026this version